Guangdong Provincial People's Hospital

This study is testing whether a new three-drug combination called ABC-14 works better than current standard treatments for adults newly diagnosed with acute myeloid leukemia (AML), a serious blood cancer. Researchers will compare ABC-14 against the traditional "3+7" chemotherapy …

This study is testing whether an 8-week exercise program done at home or in the community can improve fitness and quality of life for adults with reduced heart or lung function. Researchers will compare 200 participants who do the exercise program to those who do not. The program…

This large study aims to find out if taking a daily low-dose aspirin pill safely helps prevent heart attacks, strokes, and heart-related deaths in people with kidney failure who are on dialysis. It will follow 9,000 patients for about five years to compare outcomes between those …

This study is testing if it's safe and effective to switch dialysis patients with anemia from their current medication to a newer, longer-acting drug called pegmolesatide. It will enroll 96 patients who are currently stable on a specific type of anemia pill. The goal is to see if…

This study is testing a new artificial intelligence (AI) system designed to help diagnose common eye conditions. The AI analyzes photographs of the eye taken with standard medical cameras or smartphones. Researchers will compare the AI's diagnoses to those made by experienced eye…

This study is testing whether a dissolving tablet called nalfurafine hydrochloride can safely reduce moderate to severe itching in people receiving peritoneal dialysis for kidney failure. It will enroll 93 participants who will take the medication for 4 weeks. The main goal is to…

This is a large observational study that will follow 90,000 people in China, including those with and without kidney disease, to better understand how chronic kidney disease starts and gets worse over time. Researchers will collect real-world health data to identify risk factors …